Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 3
1997 2
1998 4
1999 2
2000 3
2001 2
2002 1
2003 1
2004 2
2006 1
2007 2
2008 1
2009 3
2010 2
2011 5
2012 2
2013 1
2014 1
2015 1
2016 2
2017 1
2018 1
2019 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Nitric oxide (NO): an emerging target for the treatment of glaucoma.
Cavet ME, Vittitow JL, Impagnatiello F, Ongini E, Bastia E. Cavet ME, et al. Among authors: impagnatiello f. Invest Ophthalmol Vis Sci. 2014 Aug 14;55(8):5005-15. doi: 10.1167/iovs.14-14515. Invest Ophthalmol Vis Sci. 2014. PMID: 25125670 Review.
New furoxan derivatives for the treatment of ocular hypertension.
Blangetti M, Rolando B, Chegaev K, Guglielmo S, Lazzarato L, Durante M, Masini E, Almirante N, Bastia E, Impagnatiello F, Fruttero R, Gasco A. Blangetti M, et al. Among authors: impagnatiello f. Bioorg Med Chem Lett. 2017 Feb 1;27(3):479-483. doi: 10.1016/j.bmcl.2016.12.041. Epub 2016 Dec 18. Bioorg Med Chem Lett. 2017. PMID: 28027869 Free article.
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs.
Galli C, Bastia E, Hubatsch DA, Toris C, Fan S, Unser A, Ahmed F, Torrejon KY, Impagnatiello F. Galli C, et al. Among authors: impagnatiello f. J Ocul Pharmacol Ther. 2023 Dec 12. doi: 10.1089/jop.2023.0102. Online ahead of print. J Ocul Pharmacol Ther. 2023. PMID: 38088745
The phenotypic characteristics of heterozygous reeler mouse.
Tueting P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R, Pesold C. Tueting P, et al. Among authors: impagnatiello f. Neuroreport. 1999 Apr 26;10(6):1329-34. doi: 10.1097/00001756-199904260-00032. Neuroreport. 1999. PMID: 10363948
NCX 1741, a Novel Nitric Oxide-Donating Phosphodiesterase-5 Inhibitor, Exerts Rapid and Long-Lasting Intraocular Pressure-Lowering in Cynomolgus Monkeys.
Bastia E, Toris C, Bukowski JM, Brambilla S, Galli C, Almirante N, Bergamini MVW, Lucarini L, Navratil T, Impagnatiello F. Bastia E, et al. Among authors: impagnatiello f. J Ocul Pharmacol Ther. 2021 May;37(4):215-222. doi: 10.1089/jop.2020.0126. Epub 2021 Feb 15. J Ocul Pharmacol Ther. 2021. PMID: 33595367
NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
Bastia E, Toris CB, Brambilla S, Galli C, Almirante N, Bergamini MVW, Masini E, Sgambellone S, Unser AM, Ahmed F, Torrejon KY, Navratil T, Impagnatiello F. Bastia E, et al. Among authors: impagnatiello f. Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):17. doi: 10.1167/iovs.62.3.17. Invest Ophthalmol Vis Sci. 2021. PMID: 33704360 Free PMC article.
47 results